EGRX logo

Eagle Pharmaceuticals (EGRX) Selling, General & Administrative Expenses

Annual SGA

$106.63 M
+$31.30 M+41.56%

December 31, 2022

Summary

Performance

1-Year Change

+41.56%

3-Year Change

+39.62%

5-Year Change

+49.3%

15-Year Change

+49.3%

EGRX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.23%
EGRX annual SGA is higher than 74.23% of companies in Healthcare sector

High & Low

All-time High

$106.63 M
EGRX annual SGA is currently at an all-time high

3-Year Low

$75.32 M
EGRX annual SGA is currently +41.56% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
EGRX previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
EGRX next annual earnings announcement has not yet been scheduled

OtherEGRXexpensesmetrics:

Annual Total Expenses

$235.65 M
EGRX annual total expenses is $235.65 million

Annual Operating Expenses

$140.71 M
EGRX annual total operating expenses is $140.71 million

Annual Cost Of Goods Sold

$94.94 M
EGRX annual cost of goods sold is $94.94 million

Annual Interest Expense

$4.04 M
EGRX annual interest expense is $4.04 million

Quarterly SGA

$27.65 M
-$309.00 K-1.11%

June 30, 2023

Summary

Performance

3-Month Change

-1.11%

1-Year Change

-24.93%

3-Year Change

+53.97%

5-Year Change

+72.96%

EGRX Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.19%
EGRX quarterly SGA is higher than 73.19% of companies in Healthcare sector

High & Low

All-time High

$36.83 M
EGRX quarterly SGA is currently -24.93% below its historical high of $36.83 million

3-Year Low

$20.32 M
EGRX quarterly SGA is currently +36.04% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
EGRX previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
EGRX next earnings announcement has not yet been scheduled

OtherEGRXexpensesmetrics:

Quarterly Total Expenses

$54.34 M
EGRX quarterly total expenses is $54.34 million

Quarterly Operating Expenses

$37.48 M
EGRX quarterly total operating expenses is $37.48 million

Quarterly Cost Of Goods Sold

$16.86 M
EGRX quarterly cost of goods sold is $16.86 million

Quarterly Interest Expense

$1.45 M
EGRX quarterly interest expense is $1.45 million

TTM SGA

$454.51 M
+$11.95 M+2.70%

June 30, 2023

Summary

Performance

3-Month Change

+304.36%

1-Year Change

+364.64%

3-Year Change

+442.93%

5-Year Change

+495.15%

EGRX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

90.29%
EGRX TTM SGA is higher than 90.29% of companies in Healthcare sector

High & Low

All-time High

$454.51 M
EGRX TTM SGA is currently at an all-time high

3-Year Low

$329.67 M
EGRX TTM SGA is currently +37.87% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
EGRX previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
EGRX next earnings announcement has not yet been scheduled

OtherEGRXexpensesmetrics:

Annual Total Expenses

$235.65 M
EGRX annual total expenses is $235.65 million

Annual Operating Expenses

$140.71 M
EGRX annual total operating expenses is $140.71 million

TTM Cost Of Goods Sold

$77.67 M
EGRX TTM cost of goods sold is $77.67 million

TTM Interest Expense

$6.49 M
EGRX TTM interest expense is $6.49 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$106.63 M
EGRX annual SGA is $106.63 million

Annual Operating Expenses

$140.71 M
EGRX annual total operating expenses is $140.71 million

Annual Cost Of Goods Sold

$94.94 M
EGRX annual cost of goods sold is $94.94 million

EGRX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+41.6%-24.9%+364.6%
3 y3 years+39.6%+54.0%+442.9%
5 y5 years+49.3%+73.0%+495.1%

EGRX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+41.6%-24.9%+36.0%at high+37.9%
5 y5-yearat high+41.6%-24.9%+66.2%at high+60.6%
alltimeall timeat high+2050.6%-24.9%+3826.6%at high+207.8%

Eagle Pharmaceuticals Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Jun 2023
-
$27.65 M(-1.1%)
$103.22 M(-8.2%)
Mar 2023
-
$27.96 M(+15.8%)
$112.40 M(+5.4%)
Dec 2022
$106.63 M(+41.6%)
$24.15 M(+2.9%)
$106.63 M(+3.7%)
Sep 2022
-
$23.46 M(-36.3%)
$102.80 M(+5.1%)
Jun 2022
-
$36.83 M(+66.0%)
$97.82 M(+26.0%)
Mar 2022
-
$22.18 M(+9.1%)
$77.63 M(+3.1%)
Dec 2021
$75.32 M(-4.2%)
$20.32 M(+10.0%)
$75.32 M(+2.9%)
Sep 2021
-
$18.48 M(+11.1%)
$73.18 M(+1.1%)
Jun 2021
-
$16.64 M(-16.3%)
$72.40 M(-1.8%)
Mar 2021
-
$19.88 M(+9.3%)
$73.72 M(-6.2%)
Dec 2020
$78.60 M(+2.9%)
$18.19 M(+2.8%)
$78.60 M(-5.2%)
Sep 2020
-
$17.70 M(-1.5%)
$82.88 M(-1.0%)
Jun 2020
-
$17.96 M(-27.5%)
$83.72 M(+0.9%)
Mar 2020
-
$24.75 M(+10.2%)
$82.98 M(+8.7%)
Dec 2019
$76.37 M(+26.2%)
$22.46 M(+21.2%)
$76.37 M(+10.1%)
Sep 2019
-
$18.54 M(+7.6%)
$69.38 M(+7.2%)
Jun 2019
-
$17.23 M(-5.0%)
$64.72 M(+2.0%)
Mar 2019
-
$18.14 M(+17.2%)
$63.48 M(+4.9%)
Dec 2018
$60.51 M(-15.3%)
$15.48 M(+11.5%)
$60.53 M(+3.7%)
Sep 2018
-
$13.88 M(-13.2%)
$58.37 M(-4.6%)
Jun 2018
-
$15.99 M(+5.2%)
$61.16 M(-10.7%)
Mar 2018
-
$15.19 M(+14.1%)
$68.46 M(-4.7%)
DateAnnualQuarterlyTTM
Dec 2017
$71.42 M(+33.9%)
$13.32 M(-20.1%)
$71.84 M(-7.4%)
Sep 2017
-
$16.67 M(-28.4%)
$77.56 M(+6.9%)
Jun 2017
-
$23.28 M(+25.3%)
$72.55 M(+18.4%)
Mar 2017
-
$18.58 M(-2.4%)
$61.26 M(+11.8%)
Dec 2016
$53.33 M(+164.5%)
$19.03 M(+63.2%)
$54.81 M(+32.4%)
Sep 2016
-
$11.66 M(-2.7%)
$41.39 M(+17.6%)
Jun 2016
-
$11.99 M(-1.1%)
$35.19 M(+24.3%)
Mar 2016
-
$12.13 M(+116.3%)
$28.31 M(+40.4%)
Dec 2015
$20.16 M(+116.2%)
$5.61 M(+2.7%)
$20.16 M(+10.5%)
Sep 2015
-
$5.46 M(+6.8%)
$18.25 M(+9.6%)
Jun 2015
-
$5.11 M(+28.2%)
$16.64 M(+17.2%)
Mar 2015
-
$3.99 M(+8.0%)
$14.20 M(+21.7%)
Dec 2014
-
$3.69 M(-4.3%)
$11.67 M(+25.2%)
Sep 2014
$9.33 M(+88.1%)
$3.85 M(+44.2%)
$9.33 M(+48.2%)
Jun 2014
-
$2.67 M(+83.8%)
$6.29 M(+118.7%)
Mar 2014
-
$1.45 M(+8.2%)
$2.88 M(-34.2%)
Dec 2013
-
$1.34 M(+63.8%)
$4.37 M(-11.8%)
Sep 2013
$4.96 M(-22.5%)
$820.50 K(-210.6%)
$4.96 M(+19.8%)
Jun 2013
-
-$742.00 K(-125.2%)
$4.14 M(-15.2%)
Mar 2013
-
$2.95 M(+52.7%)
$4.88 M(+152.7%)
Dec 2012
-
$1.93 M
$1.93 M
Sep 2012
$6.40 M
-
-

FAQ

  • What is Eagle Pharmaceuticals annual SGA?
  • What is the all time high annual SGA for Eagle Pharmaceuticals?
  • What is Eagle Pharmaceuticals annual SGA year-on-year change?
  • What is Eagle Pharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for Eagle Pharmaceuticals?
  • What is Eagle Pharmaceuticals quarterly SGA year-on-year change?
  • What is Eagle Pharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for Eagle Pharmaceuticals?
  • What is Eagle Pharmaceuticals TTM SGA year-on-year change?

What is Eagle Pharmaceuticals annual SGA?

The current annual SGA of EGRX is $106.63 M

What is the all time high annual SGA for Eagle Pharmaceuticals?

Eagle Pharmaceuticals all-time high annual SGA is $106.63 M

What is Eagle Pharmaceuticals annual SGA year-on-year change?

Over the past year, EGRX annual SGA has changed by +$31.30 M (+41.56%)

What is Eagle Pharmaceuticals quarterly SGA?

The current quarterly SGA of EGRX is $27.65 M

What is the all time high quarterly SGA for Eagle Pharmaceuticals?

Eagle Pharmaceuticals all-time high quarterly SGA is $36.83 M

What is Eagle Pharmaceuticals quarterly SGA year-on-year change?

Over the past year, EGRX quarterly SGA has changed by -$9.18 M (-24.93%)

What is Eagle Pharmaceuticals TTM SGA?

The current TTM SGA of EGRX is $454.51 M

What is the all time high TTM SGA for Eagle Pharmaceuticals?

Eagle Pharmaceuticals all-time high TTM SGA is $454.51 M

What is Eagle Pharmaceuticals TTM SGA year-on-year change?

Over the past year, EGRX TTM SGA has changed by +$356.69 M (+364.64%)